Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 9/20 | 0.75 |
| ▸ | HDAC6 | Q9UBN7 | 9/20 | 0.75 |
| ▸ | HDAC1 | Q13547 | 10/20 | 0.62 |
| ▸ | HDAC8 | Q9BY41 | 9/20 | 0.62 |
| ▸ | HDAC2 | Q92769 | 8/20 | 0.62 |
| ▸ | HDAC4 | P56524 | 4/20 | 0.62 |
| ▸ | HDAC10 | Q969S8 | 3/20 | 0.62 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.62 |
| ▸ | MAOA | P21397 | 1/20 | 0.54 |
| ▸ | MAOB | P27338 | 1/20 | 0.54 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.52 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.52 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.52 |
| ▸ | MEF2D | Q14814 | 1/20 | 0.51 |
| ▸ | BCHE | P06276 | 1/20 | 0.51 |
| ▸ | ACHE | P22303 | 1/20 | 0.51 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12592142 | 0.88 | HDAC3 (0.71) | HDAC3HDAC6HDAC1HDAC8HDAC2 | |
| SCHEMBL12150981 | 0.86 | HDAC6 (1.00) | HDAC3HDAC6HDAC1HDAC8HDAC2 | |
| SCHEMBL24294041 | 0.84 | HDAC3 (0.69) | HDAC3HDAC6HDAC1HDAC8HDAC2 | |
| SCHEMBL8256427 | 0.80 | HDAC3 (0.68) | HDAC3HDAC6HDAC1HDAC8HDAC2 | |
| SCHEMBL17483891 | 0.79 | HDAC1 (0.71) | HDAC3HDAC6HDAC1HDAC8HDAC2 | |
| SCHEMBL13949775 | 0.79 | HDAC3 (0.65) | HDAC3HDAC6HDAC1HDAC8HDAC2 | |
| SCHEMBL19666006 | 0.77 | HDAC6 (1.00) | HDAC3HDAC6HDAC1HDAC8HDAC2 | |
| SCHEMBL19678427 | 0.77 | HDAC6 (1.00) | HDAC3HDAC6HDAC1HDAC8HDAC2 | |
| SCHEMBL16653780 | 0.77 | HDAC6 (1.00) | HDAC3HDAC6HDAC1HDAC8HDAC2 | |
| SCHEMBL19666090 | 0.77 | HDAC6 (1.00) | HDAC3HDAC6HDAC1HDAC8HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210060014-A1 | COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS | CERENO SCIENTIFIC AB (SE) | 2021-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210060014-A1 | COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS | HDAC3, HDAC1, HDAC2 | HDAC3 1/4885HDAC6 10/4885HDAC1 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.